Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Co-Existent Endometrial and Fallopian Tube Carcinoma, Molecular and Pathological Features for Risk Stratification.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026

Same author

Laryngopharyngeal Liposarcoma: A (Somewhat Docile) Wolf in Sheep's Clothing.

Head and neck pathology·2026

Same author

Pathologic Assessment of Retroperitoneal Sarcomas: A Position Paper By the Transatlantic Australasian Retroperitoneal Sarcoma Working Group.

The American journal of surgical pathology·2026

Same author

CDKN2A deletion in p16-negative/HPV-positive head and neck squamous cell carcinoma: Highlighting the molecular basis behind the limitation of relying on p16 immunohistochemistry as a surrogate marker for HPV involvement.

Histopathology·2025

Same author

Comparison of Endometrial Serous and Gastric HER2 Immunohistochemistry Scoring Schemes in Endometrial Carcinomas With Aberrant p53 Expression: Reproducibility and In Situ Hybridization Correlation.

International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists·2025

Same author

A Mediastinal Neuroblastoma in a 31-Year-Old Woman Presenting After a Prolonged Indolent Course: A Report and Review of Literature.

International journal of surgical pathology·2025

Search research articles

Related Experiment Video

Updated: Aug 28, 2025

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

Updates in Pathology for Retroperitoneal Soft Tissue Sarcoma.

Tanner Mack^1,2, Bibianna Purgina^1,2

¹Department of Pathology and Laboratory Medicine, The Ottawa Hospital, University of Ottawa, Ottawa, ON K1H 8L6, Canada.

Current Oncology (Toronto, Ont.)

|September 22, 2022

Summary

Retroperitoneal soft tissue tumors are rare, with most being malignant sarcomas. This review details their pathology, aiding surgical oncologists in diagnosing and treating these challenging tumors.

Keywords:

GIST leiomyosarcoma liposarcoma malignant peripheral nerve sheath tumor molecular pathology retroperitoneum sarcoma solitary fibrous tumor

More Related Videos

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Related Experiment Videos

Last Updated: Aug 28, 2025

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Area of Science:

Oncology
Pathology
Surgical Oncology

Background:

Retroperitoneal tumors are exceptionally rare, with over 70% of primary soft tissue types being malignant.
Common retroperitoneal sarcomas include liposarcoma and leiomyosarcoma, but other sarcomas and benign mesenchymal tumors also occur.
The heterogeneity and overlapping microscopic features of sarcomas present diagnostic challenges for pathologists.

Purpose of the Study:

To review the pathology of retroperitoneal soft tissue sarcomas for surgical oncologists.
To discuss less common sarcomas and benign mesenchymal tumors that can mimic sarcomas.
To highlight the importance of accurate tumor classification for prognostication and targeted therapies.

Main Methods:

Literature review focusing on the pathology of retroperitoneal soft tissue tumors.
Discussion of common and uncommon sarcomas.
Inclusion of benign mesenchymal tumors that mimic sarcomas.

Main Results:

Primary retroperitoneal soft tissue tumors are predominantly malignant sarcomas.
Liposarcoma and leiomyosarcoma are the most frequent types.
Accurate classification is crucial for patient outcomes and treatment selection.

Conclusions:

Understanding the pathology of retroperitoneal sarcomas is vital for surgical oncologists.
Distinguishing between malignant sarcomas and benign mimics is critical.
Precise diagnosis impacts prognostication and the application of novel therapeutic strategies.